Literature DB >> 25921664

Screening and detection of hepatocellular carcinoma.

Heather N Simpson1, Brendan M McGuire2.   

Abstract

The increasing incidence of hepatocellular carcinoma (HCC) has led to the need to identify patients at risk for HCC so that a program of screening can be undertaken. Screening for HCC has led to earlier diagnosis of tumors and thus has aided in initiating optimal medical treatment earlier in the disease course. Advances in radiological techniques and the identification of more accurate serum tests to diagnose HCC continue to be important areas of study and exploration. In particular, there have been efforts to develop new tumor markers to aid in the diagnosis of HCC and guide therapy of tumors.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; Screening; Treatment; Tumors

Mesh:

Substances:

Year:  2015        PMID: 25921664     DOI: 10.1016/j.cld.2015.01.004

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  7 in total

1.  International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007.

Authors:  Jessica L Petrick; Megan Braunlin; Mathieu Laversanne; Patricia C Valery; Freddie Bray; Katherine A McGlynn
Journal:  Int J Cancer       Date:  2016-06-28       Impact factor: 7.396

Review 2.  Surveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver Cirrhosis.

Authors:  Jens U Marquardt; Marc Nguyen-Tat; Peter R Galle; Marcus A Wörns
Journal:  Visc Med       Date:  2016-04-08

3.  Impacts of CCL4 gene polymorphisms on hepatocellular carcinoma susceptibility and development.

Authors:  Bin Wang; Ying-Erh Chou; Ming-Yu Lien; Chen-Ming Su; Shun-Fa Yang; Chih-Hsin Tang
Journal:  Int J Med Sci       Date:  2017-07-19       Impact factor: 3.738

4.  Diagnostic Imaging of Hepatocellular Carcinoma - A Pictorial Essay.

Authors:  Tomasz K Nowicki; Karolina Markiet; Edyta Szurowska
Journal:  Curr Med Imaging Rev       Date:  2017-05

5.  Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma.

Authors:  Bin Wang; Chao-Bin Yeh; Ming-Yu Lein; Chen-Ming Su; Shun-Fa Yang; Yu-Fan Liu; Chih-Hsin Tang
Journal:  Int J Med Sci       Date:  2016-04-09       Impact factor: 3.738

6.  Variations in the AURKA Gene: Biomarkers for the Development and Progression of Hepatocellular Carcinoma.

Authors:  Bin Wang; Chin-Jung Hsu; Chia-Hsuan Chou; Hsiang-Lin Lee; Whei-Ling Chiang; Chen-Ming Su; Hsiao-Chi Tsai; Shun-Fa Yang; Chih-Hsin Tang
Journal:  Int J Med Sci       Date:  2018-01-01       Impact factor: 3.738

7.  Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.

Authors:  Bin Wang; Chin-Jung Hsu; Hsiang-Lin Lee; Chia-Hsuan Chou; Chen-Ming Su; Shun-Fa Yang; Chih-Hsin Tang
Journal:  Int J Med Sci       Date:  2018-04-03       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.